Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Use of furan alkyls for preparing a drug for treating obesity and cosmetically treating overweight

A technology for alkyl furan and obesity is applied in the field of use of alkyl furan in the preparation of medicines for treating obesity and cosmetic treatment of overweight, can solve the problems of unsatisfactory active ingredients and the like, and achieves an increase in blood flow. horizontal effect

Inactive Publication Date: 2007-05-09
LAB EXPANSCIENCE
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, many active ingredients for weight loss are still being researched, as the known active ingredients are not fully satisfactory

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of furan alkyls for preparing a drug for treating obesity and cosmetically treating overweight
  • Use of furan alkyls for preparing a drug for treating obesity and cosmetically treating overweight
  • Use of furan alkyls for preparing a drug for treating obesity and cosmetically treating overweight

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0085] Cosmetic products for diabetic patients to remove freckles (total amount: 100g)

[0086] %

[0087] water 64.83

[0088] Lupine Peptides 7

[0089] Furan unsaponifiable from avocado 2

[0090] Butanediol 3

[0091] Cetyl Alcohol 6

[0092] Alkyl Lactate C12-13 2

[0093] mineral oil 7

[0094] Ceteareth 20 (Ceteareth 20) 2

[0095] stearic acid 1

[0096] Extract of White Mulberry 1

[0097] Vitamin E 0.50

[0098] Propylene glycol 0.56

[0099] Disodium EDTA 0.52

[0100] Triethanolamine 0.80

[0101] Preservatives 0.30

[0102] Citric acid 0.25

[0103] Methylparaben 0.11

[0104] Stearyl ether-2 1

[0105] Sodium metabisulfite 0.05

[0106] Sodium sulfite 0.05

[0107] Propylparaben 0.03

Embodiment 2

[0109] Cream for diabetic skin care (total amount: 100g)

[0110] %

[0111] Medical Vaseline 6.00

[0112] Hydrogenated Palm Oil 4.00

[0113] Glyceryl caprylate 2.00

[0114] (glycerol caprylo caprate)

[0115] Sucrose ester 7 (Sucro ester 7) 6.00

[0116] (Sucrose Distearate)

[0117] Squalane 1.00

[0118] Candelilla Wax 2.00

[0119] Sucrose ester 11 (sucrose stearate) 0.50

[0120] 2-Alkylfuran 2.00

[0121] Sunflower Concentrate 2.00

[0122] Glycerin 5.00

[0123] Glucodextrin 1.00

[0124] Tromethamine 0.01

[0125] Xanthan gum 0.20

[0126] Hydroxymethylglycinate A 0.60

[0127] Citric acid 0.32

[0128] Cyclomethiconol 5.00

[0129] Ceramide / Cholesterol 0.60

[0130] Purified water 5.00

Embodiment 3

[0132] Protective Cream for Diabetic Skin (Total: 100g)

[0133] %

[0134] Squalane 1.00

[0135] Pentaerythritol nitrate 4.00

[0136] Decylvalerate 4.00

[0137] Cetyl glucoside 2.00

[0138] Lauryl ether 23OE 1.00

[0139] Cutina CBSV 1.00

[0140] Beeswax 0.50

[0141] Myristyl myristate 1.00

[0142] Preservatives 0.30

[0143] Thick Vaseline 5.00

[0144] Gelled Squalane 3.00

[0145] Avocado furan oil 10.00

[0146] Purified water 56.51

[0147] Phenoxyethanol 0.80

[0148] Sodium EDTA 0.10

[0149] Citric acid 0.14

[0150] Potassium sorbate 0.45

[0151] Glycerin 5.00

[0152] Thickener 0.50

[0153] Sodium hydroxide 0.30

[0154] Polyacrylamide Gel 60° 1.00

[0155] Vitamin E Acetate 35° 0.50

[0156] Spice 0.50

[0157] Lupine Peptides 1.00

[0158] Cyclic polydimethylsiloxane 7.00

[0159] Silic...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to using one or several synthetic or natural furan alkyls for preparing a drug for preventing and / or treating diabetes and insulin resistance, thereby preventing the risks of cardiovascular, nervous, cutaneous, renal, ocular and infectious diseases. The use of one or several synthetic or natural furan alkyls for cosmetically treating diabetes related skin disorders is also disclosed.

Description

technical field [0001] The present invention relates to the preparation of one or more synthetic or natural alkyl furans for the prevention and / or treatment of diabetes, insulin resistance, obesity, overweight, dyslipidemia and the resulting cardiovascular, nervous, skin , Kidney, Eye and Infectious Diseases Dangerous Use in Drugs. The present invention also relates to the use of one or more natural or synthetic alkylfurans for the cosmetic treatment of localized overweight and / or cellulite and for diabetic skin conditions. Background technique [0002] Diabetes is a chronic disease, often associated with other diseases such as overweight or dyslipidemia, or with the risk of cardiovascular disease. Diabetes is also a leading cause of blindness in patients aged 25 to 74. Those with 2 to 4 episodes of diabetes were more likely to have heart disease, and those with 5 episodes were more likely to have a stroke. Diabetes is defined as a state of chronic hyperglycemia: fasting ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/341A61K8/49A61Q19/00A61P3/04
CPCA61K31/341A61P13/12A61P17/00A61P25/00A61P27/02A61P3/00A61P31/00A61P3/04A61P3/06A61P3/08A61P5/50A61P7/12A61P9/10A61P3/10
Inventor A·皮奇里利P·姆西卡N·皮卡尔迪
Owner LAB EXPANSCIENCE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products